As a division of SCHA, our mission is to serve members by providing solutions to “pain points,” those day-to-day operational problems and challenges that come with running a top-quality healthcare facility. Our goal is to be the top-of-mind, first-call resource for healthcare leaders looking for ways to ease their pain. For more information, visit Solvent Networks, follow us on Linked In or watch our video HERE. Please also continue to monitor SCHA’s COVID-19 webpage for the latest updates on responses and resources.
Supplier Payments During a Crisis:
Best Practices & Strategies from Leading Healthcare Providers
The healthcare industry is facing unprecedented financial challenges in response to the coronavirus pandemic. Endorsed partner, CommerceHealthcare, sympathizes with healthcare leaders who must manage through this complex and multifaceted financial situation. During this on-demand webinar opportunity, CommerceHealthcare will discuss:
- Minimizing the impact of revenue loss as a result of COVID-19.
- Enabling providers to transition towards a more flexible workflow and workforce with technology.
- Reducing paper processes to improve back office and accounting efficiencies, but also foster a safer environment for patients and staff.
- Steps healthcare leaders can take today to help prepare their organizations for future disruptions to supplier payment operations.
Click HERE to join the on-demand webinar and examine supplier payment strategies and best practices that leading healthcare organizations are utilizing to successfully respond to COVID-19.
Vizient Looks to Biosimilars in Response to COVID-19 Driven Inflation
Vizient says its 2020 drug price forecast shows COVID-19 has driven up costs and advises member health groups to hedge against drug price inflation, which will reach 3.29 percent in 2021, via the use of biosimilars.
“The COVID-19 pandemic has had an extraordinary impact on hospitals and health systems. As a result, any increase in pricing, even a modest one, makes the challenge of economic recovery even more difficult,” said Dan Kistner, PharmD, group senior vice president of pharmacy solutions at Vizient.
The report notes the growing market share of biosimilars, which fall under the heading of specialty drugs. The authors of the report said the overwhelming focus lately on the clinical and economic impacts of the COVID-19 crisis makes it easy to overlook the economic benefits of the increased adoption of biosimilars. “Biosimilars should not be viewed as an alternative endeavor separate from COVID-19 recovery, but rather as an integral component of improvement plans,” they said. Read more HERE.
Integrating the POST Directives into ED Workflows
Legislation approved by the General Assembly enables S.C. physicians, nurse practitioners and physician’s assistants to execute an end-of-life medical order known as a physician order for scope of treatment (POST), using a standard form developed by the S.C. Department of Health and Environmental Control. SCHA is offering an online workshop this fall to equip physicians and other healthcare professionals with the knowledge and resources to begin using the POST form.
But hospitals may need help integrating POST directives into their emergency department workflows. Collective Medical, an endorsed partner of Solvent Networks, offers a healthcare information technology platform that has been used in other states to connect with the POST or POLST database and offer better guidance for patient care, especially in critical conditions.
Oregon is one state that has enabled Collective access to the POLST database with great results. With this system, a patient presenting at the hospital with a serious condition is entered into the system. Patient information is immediately checked against the Collective platform for any care guidelines, and the platform queries the state database for any orders on file.
If there is an order, that order is included on a real-time event notification which is delivered directly to the ED through an EDie notification. The EDie notification is designed to be read in 60 seconds or less and contains only the most important information (based on qualifications set by the individual hospital).
For more information, contact Andrew Reeve, SVP of Business Development at Collective Medical.
Contact Solvent Networks to set up a meeting with any of our endorsed partners or SCHA corporate sponsors. We’re here for the health of your business.
